scispace - formally typeset
C

Claude Leclerc

Researcher at French Institute of Health and Medical Research

Publications -  297
Citations -  15655

Claude Leclerc is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Antigen & Epitope. The author has an hindex of 69, co-authored 295 publications receiving 14915 citations. Previous affiliations of Claude Leclerc include Academy of Sciences of the Czech Republic & Pasteur Institute.

Papers
More filters
Journal ArticleDOI

Neonatal adaptive immunity comes of age

TL;DR: This review focuses on the new understanding in mice and, where it is clear that related phenomena occur, in humans.
Journal ArticleDOI

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.

TL;DR: Mice and guinea pigs vaccinated with the recombinant strain BCG::RD1-2F9 were better protected against challenge with M. tuberculosis, showing less severe pathology and reduced dissemination of the pathogen, as compared with control animals immunized with BCG alone.
Journal ArticleDOI

The Adenylate Cyclase Toxin of Bordetella pertussis Binds to Target Cells via the αMβ2 Integrin (Cd11b/Cd18)

TL;DR: The cellular distribution of CD11b, mostly on neutrophils, macrophages, and dendritic and natural killer cells, supports a role for CyaA in disrupting the early, innate antibacterial immune response.
Journal ArticleDOI

Coactivation of Syk Kinase and MyD88 Adaptor Protein Pathways by Bacteria Promotes Regulatory Properties of Neutrophils

TL;DR: It is shown that after bacterial stimulation, and in contrast to monocytes and macrophages, murine neutrophils contributed poorly to inflammatory responses; however, they secreted high amounts of the anti-inflammatory cytokine IL-10 in a DAP12 adaptor-Syk kinase and MyD88 adaptor -dependent manner.
Journal ArticleDOI

Dissection of ESAT-6 System 1 of Mycobacterium tuberculosis and Impact on Immunogenicity and Virulence

TL;DR: ESX-1-complemented BCG and M. microti strains were more efficiently engulfed by bone-marrow-derived macrophages than controls, and this may account for the enhanced in vivo growth of ESX- 1-carrying strains.